THERAPEUTIC BINDING MOLECULE THAT BINDS TO CCR9

The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	REES David Gareth, IRVING Lorraine, SCHOFIELD Darren Jonathan, CARIUK Peter, NYS Josquin Arnaud, RILEY Aidan, HUNTINGTON Catherine Eugenie Chaillan, ROBINSON Matthew, THOM Albert George
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention. La invención se refiere a moléculas de unión, tales como anticuerpos, que se unen al receptor de quimiocinas CCR9. Más particularmente, la invención se refiere al tratamiento de enfermedades o afecciones mediadas por CCR9, tales como la enfermedad Inflamatoria Intestinal (EII), y a métodos que, para la detección de CCR9, utilizan las moléculas de unión de la invención.